Illumina Inc (ILMN)
Company overview
Illumina. The world's No. 1 in next-generation gene-sequencing equipment. It provides core infrastructure for the precision-medicine and genetic-diagnostics markets.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
Illumina Inc is classified under the Biotech & Health sector. See peers below.
Illumina Inc key financials
Based on SEC filings · latest quarter (TTM)
Tap a metric name to see its meaning in the glossary.
ETFs holding Illumina Inc
Per SEC N-PORT · 2026-04-30 · by weight · factual
ILMN on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — valuation and growth vs the Biotech & Health average
Peers · Biotech & Health
ILMN FAQ
What is Illumina Inc (ILMN)?
Illumina. The world's No. 1 in next-generation gene-sequencing equipment. It provides core infrastructure for the precision-medicine and genetic-diagnostics markets.
What sector is Illumina Inc in?
Illumina Inc is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are Illumina Inc's key financials?
Based on the latest quarter (TTM) from SEC filings: Revenue growth (YoY) 1.3%, Operating margin 19.2%, Net margin 19.4%, ROE 31.2%. Definitions and interpretation are available on Stocklore.
Where can I analyze Illumina Inc (ILMN) stock?
On Stocklore you can see ILMN's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, 45-day delay), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.